Showing results (581-590 of 635) with videos related to
Sort By:
Pageof 64
Applied Clinical Informatics|July 14, 2026
Designing Granular Consent Tools for Sensitive Health Data: Challenges, User Needs, and Stakeholder GuidanceReid A Cooper, Mengyi Wei, Martha Kaiser, et al.JCO Precision Oncology|November 14, 2025
Actionable Genomic Alterations in Large Cell Neuroendocrine Carcinoma: A European Case Series of Patients Treated With a Small Molecule InhibitorFrank W J Heijboer, Marta Brambilla, Mario Occhipinti, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2020
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology StudyAlbrecht Stenzinger, Volker Endris, Jan Budczies, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2019
Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical ArtifactsDaniel Kazdal, Volker Endris, Michael Allgäuer, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2025
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 68Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient managementFrederik L Giesel, Stefan A Koerber, Boris Hadaschik, et al.Nature Communications|May 19, 2025
Wnt/β-catenin activation by mutually exclusive FBXW11 and CTNNB1 hotspot mutations drives salivary basal cell adenomaKim Wong, Justin A Bishop, Ilan Weinreb, et al.Gastroenterology|December 5, 2021
The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer PatientsLena Bohaumilitzky, Klaus Kluck, Robert Hüneburg, et al.Cancer Medicine|November 15, 2021
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancerIsabel Grote, Stephan Bartels, Leonie Kandt, et al.Targeted Oncology|July 17, 2026
From Recommendation to Implementation: Clinical Outcomes of a Single-Center Molecular Tumor BoardTabea Fröhlich, Ulrich Lehmann, Tanja Reineke-Plaaß, et al.Journal for Immunotherapy of Cancer|March 29, 2020
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization ProjectDiana M Merino, Lisa M McShane, David Fabrizio, et al.Pageof 64